• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

支气管肺泡灌洗液中的间质评分以及白细胞介素-4受体α(IL-4Rα)、蛋白酶激活受体-2(PAR-2)和基质金属蛋白酶-7(MMP-7)的浓度可能是区分特发性间质性肺炎的有用标志物。

Interstitial Score and Concentrations of IL-4Rα, PAR-2, and MMP-7 in Bronchoalveolar Lavage Fluid Could Be Useful Markers for Distinguishing Idiopathic Interstitial Pneumonias.

作者信息

Bruzova Magdalena, Pavlova Martina, Matej Radoslav, Sterclova Martina, Vasakova Martina

机构信息

Department of Pathology and Molecular Medicine, 3rd Faculty of Medicine, Charles University and Thomayer University Hospital, Videnska 800, 140 59 Prague, Czech Republic.

Department of Respiratory Medicine, University Hospital Pilsen, Edvarda Benese 1128/13, 305 99 Pilsen, Czech Republic.

出版信息

Diagnostics (Basel). 2021 Apr 13;11(4):693. doi: 10.3390/diagnostics11040693.

DOI:10.3390/diagnostics11040693
PMID:33924683
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8070528/
Abstract

Idiopathic interstitial pneumonia (IIP) entails a variable group of lung diseases of unknown etiology. Idiopathic pulmonary fibrosis, nonspecific interstitial pneumonia, interstitial lung diseases related to connective tissue disease (CTD-ILD), and hypersensitivity pneumonitis (HP) can manifest with similar clinical, radiological, and histopathological features. In a differential diagnosis, biomarkers can play a significant role. We assume that levels of specific cyto- or chemokines or their receptors can signal pathogenetic processes in the lungs. Eighty patients with different types of idiopathic interstitial pneumonia were enrolled in this study. Cell counts and concentrations of tumor necrosis factor (TNF)-α, interleukin-4 receptor α, proteinase-activated receptor (PAR)-2, matrix metalloproteinase (MMP)-7, and B cell-activating factor were measured in bronchoalveolar lavage fluid using commercial ELISA kits. High resolution computer tomography results were evaluated using alveolar and interstitial (IS) score scales. Levels of TNF-α were significantly higher in HP compared to fibrosing IIP ( < 0.0001) and CTD-ILD ( = 0.0381). Concentrations of IL-4Rα, PAR-2, and MMP-7 were positively correlated with IS ( = 0.0009; = 0.0256; = 0.0015, respectively). Since TNF-α plays a major role in inflammation, our results suggest that HP is predominantly an inflammatory disease. From the positive correlation with IS we believe that IL-4Rα, PAR-2, and MMP-7 could serve as fibroproliferative biomarkers in differential diagnosis of IIP.

摘要

特发性间质性肺炎(IIP)是一组病因不明的肺部疾病。特发性肺纤维化、非特异性间质性肺炎、与结缔组织病相关的间质性肺病(CTD-ILD)和过敏性肺炎(HP)可表现出相似的临床、放射学和组织病理学特征。在鉴别诊断中,生物标志物可发挥重要作用。我们假设特定细胞因子或趋化因子及其受体的水平能够反映肺部的致病过程。本研究纳入了80例不同类型的特发性间质性肺炎患者。使用商用ELISA试剂盒检测支气管肺泡灌洗液中的细胞计数以及肿瘤坏死因子(TNF)-α、白细胞介素-4受体α、蛋白酶激活受体(PAR)-2、基质金属蛋白酶(MMP)-7和B细胞活化因子的浓度。使用肺泡和间质(IS)评分量表评估高分辨率计算机断层扫描结果。与纤维化性IIP(<0.0001)和CTD-ILD(=0.0381)相比,HP患者的TNF-α水平显著更高。IL-4Rα、PAR-2和MMP-7的浓度与IS呈正相关(分别为=0.0009;=0.0256;=0.0015)。由于TNF-α在炎症中起主要作用,我们的结果表明HP主要是一种炎症性疾病。基于与IS的正相关关系,我们认为IL-4Rα、PAR-2和MMP-7可作为IIP鉴别诊断中的纤维增殖生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c670/8070528/17c8bce32157/diagnostics-11-00693-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c670/8070528/8f33f3895877/diagnostics-11-00693-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c670/8070528/6456855c3df9/diagnostics-11-00693-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c670/8070528/8ec6f97afb88/diagnostics-11-00693-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c670/8070528/17c8bce32157/diagnostics-11-00693-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c670/8070528/8f33f3895877/diagnostics-11-00693-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c670/8070528/6456855c3df9/diagnostics-11-00693-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c670/8070528/8ec6f97afb88/diagnostics-11-00693-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c670/8070528/17c8bce32157/diagnostics-11-00693-g004.jpg

相似文献

1
Interstitial Score and Concentrations of IL-4Rα, PAR-2, and MMP-7 in Bronchoalveolar Lavage Fluid Could Be Useful Markers for Distinguishing Idiopathic Interstitial Pneumonias.支气管肺泡灌洗液中的间质评分以及白细胞介素-4受体α(IL-4Rα)、蛋白酶激活受体-2(PAR-2)和基质金属蛋白酶-7(MMP-7)的浓度可能是区分特发性间质性肺炎的有用标志物。
Diagnostics (Basel). 2021 Apr 13;11(4):693. doi: 10.3390/diagnostics11040693.
2
CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseases.血清、BAL 液和肺泡巨噬细胞培养上清液中的 CCL18 在间质性肺疾病中的作用。
Respir Med. 2013 Sep;107(9):1444-52. doi: 10.1016/j.rmed.2013.06.004. Epub 2013 Jul 5.
3
Comparison of clinical courses and mortality of connective tissue disease-associated interstitial pneumonias and chronic fibrosing idiopathic interstitial pneumonias.结缔组织病相关性间质性肺炎与慢性纤维化特发性间质性肺炎的临床过程和死亡率比较。
Kaohsiung J Med Sci. 2019 Jun;35(6):365-372. doi: 10.1002/kjm2.12066. Epub 2019 Mar 26.
4
Biomarkers of fibroproliferative healing in fibrosing idiopathic interstitial pneumonias.特发性肺纤维化中纤维增生性愈合的生物标志物
Open Respir Med J. 2012;6:160-4. doi: 10.2174/1874306401206010160. Epub 2012 Dec 28.
5
Association between Pepsin in Bronchoalveolar Lavage Fluid and Prognosis of Chronic Fibrosing Interstitial Lung Disease.支气管肺泡灌洗术中胃蛋白酶与慢性纤维化间质性肺病预后的关系
Tohoku J Exp Med. 2018 Nov;246(3):147-153. doi: 10.1620/tjem.246.147.
6
Current status of idiopathic nonspecific interstitial pneumonia.特发性非特异性间质性肺炎的现状。
Semin Respir Crit Care Med. 2012 Oct;33(5):440-9. doi: 10.1055/s-0032-1325155. Epub 2012 Sep 21.
7
Bronchoalveolar lavage fluid cellular characteristics, functional parameters and cytokine and chemokine levels in interstitial lung diseases.间质性肺疾病中支气管肺泡灌洗液体细胞特征、功能参数以及细胞因子和趋化因子水平
Scand J Immunol. 2009 Mar;69(3):268-74. doi: 10.1111/j.1365-3083.2008.02222.x.
8
Clinical characteristics of patients with anti-aminoacyl-tRNA synthetase antibody positive idiopathic interstitial pneumonia.抗氨酰-tRNA 合成酶抗体阳性特发性间质性肺炎患者的临床特征。
Respir Med. 2017 Nov;132:189-194. doi: 10.1016/j.rmed.2017.10.020. Epub 2017 Oct 28.
9
Are There Differences in Inflammatory and Fibrotic Pathways between IPAF, CTD-ILDs, and IIPs? A Single-Center Pilot Study.特发性肺泡蛋白沉积症、结缔组织病相关间质性肺疾病和特发性间质性肺炎之间的炎症和纤维化途径是否存在差异?一项单中心初步研究。
Int J Mol Sci. 2022 Dec 2;23(23):15205. doi: 10.3390/ijms232315205.
10
Bronchoalveolar lavage cell profiles and proteins concentrations can be used to phenotype extrinsic allergic alveolitis patients.支气管肺泡灌洗细胞谱和蛋白质浓度可用于对过敏性肺炎患者进行表型分析。
Multidiscip Respir Med. 2019 Mar 12;14:13. doi: 10.1186/s40248-019-0175-6. eCollection 2019.

引用本文的文献

1
Diagnostic Application of Bronchoalveolar Lavage Fluid Analysis in Cases of Idiopathic Pulmonary Fibrosis in which Diagnosis Cannot Be Confirmed by High-Resolution Computed Tomography.支气管肺泡灌洗术在高分辨率计算机断层扫描无法确诊的特发性肺纤维化病例中的诊断应用
Lung. 2025 Jan 3;203(1):16. doi: 10.1007/s00408-024-00758-3.
2
Under the dual effect of inflammation and pulmonary fibrosis, CTD-ILD patients possess a greater susceptibility to VTE.在炎症和肺纤维化的双重作用下,结缔组织病相关间质性肺病(CTD-ILD)患者发生静脉血栓栓塞症(VTE)的易感性更高。
Thromb J. 2024 Apr 4;22(1):34. doi: 10.1186/s12959-024-00599-3.
3
Diagnosis of Fibrotic Hypersensitivity Pneumonitis: Is There a Role for Biomarkers?

本文引用的文献

1
Diagnosis of Hypersensitivity Pneumonitis in Adults. An Official ATS/JRS/ALAT Clinical Practice Guideline.成人过敏性肺炎的诊断。美国胸科学会/日本呼吸学会/拉丁美洲胸科学会临床实践指南。
Am J Respir Crit Care Med. 2020 Aug 1;202(3):e36-e69. doi: 10.1164/rccm.202005-2032ST.
2
Editorial: Alveolar Macrophages in Lung Inflammation and Resolution.社论:肺泡巨噬细胞在肺部炎症与消散过程中的作用
Front Immunol. 2019 Sep 24;10:2275. doi: 10.3389/fimmu.2019.02275. eCollection 2019.
3
New therapeutic strategies for IPF: Based on the "phagocytosis-secretion-immunization" network regulation mechanism of pulmonary macrophages.
纤维化性过敏性肺炎的诊断:生物标志物有作用吗?
Life (Basel). 2023 Feb 17;13(2):565. doi: 10.3390/life13020565.
4
Serum MMP-9 and SAA in the Diagnosis of Severe Pneumonia Caused by Radiotherapy of Esophageal Cancer.血清基质金属蛋白酶-9和血清淀粉样蛋白A在食管癌放疗所致重症肺炎诊断中的应用
Evid Based Complement Alternat Med. 2021 Aug 5;2021:6032546. doi: 10.1155/2021/6032546. eCollection 2021.
特发性肺纤维化(IPF)的新型治疗策略:基于肺巨噬细胞的“吞噬-分泌-免疫”网络调控机制。
Biomed Pharmacother. 2019 Oct;118:109230. doi: 10.1016/j.biopha.2019.109230. Epub 2019 Jul 24.
4
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.特发性肺纤维化诊断。美国胸科学会/欧洲呼吸学会/日本呼吸学会/拉丁美洲胸科学会临床实践指南。
Am J Respir Crit Care Med. 2018 Sep 1;198(5):e44-e68. doi: 10.1164/rccm.201807-1255ST.
5
[The role of B cell activating factor in the differential diagnosis of usual interstitial pneumonia].[B细胞活化因子在寻常型间质性肺炎鉴别诊断中的作用]
Zhonghua Jie He He Hu Xi Za Zhi. 2018 Jul 12;41(7):544-550. doi: 10.3760/cma.j.issn.1001-0939.2018.07.008.
6
Treatment of connective tissue disease-associated interstitial lung disease: the pulmonologist's point of view.结缔组织病相关间质性肺疾病的治疗:肺科医生的观点。
Korean J Intern Med. 2017 Jul;32(4):600-610. doi: 10.3904/kjim.2016.212. Epub 2017 Jun 30.
7
MMP-7 is a predictive biomarker of disease progression in patients with idiopathic pulmonary fibrosis.基质金属蛋白酶-7是特发性肺纤维化患者疾病进展的预测性生物标志物。
ERJ Open Res. 2017 Mar 22;3(1). doi: 10.1183/23120541.00074-2016. eCollection 2017 Jan.
8
Hypersensitivity pneumonitis: a complex lung disease.过敏性肺炎:一种复杂的肺部疾病。
Clin Mol Allergy. 2017 Mar 7;15:6. doi: 10.1186/s12948-017-0062-7. eCollection 2017.
9
Validation of the prognostic value of MMP-7 in idiopathic pulmonary fibrosis.基质金属蛋白酶-7在特发性肺纤维化中预后价值的验证
Respirology. 2017 Apr;22(3):486-493. doi: 10.1111/resp.12920. Epub 2016 Oct 19.
10
Pulmonary Macrophages: A New Therapeutic Pathway in Fibrosing Lung Disease?肺巨噬细胞:纤维化性肺部疾病的新治疗途径?
Trends Mol Med. 2016 Apr;22(4):303-316. doi: 10.1016/j.molmed.2016.02.004. Epub 2016 Mar 12.